Evaluation of Diffusion-weighted Magnetic Resonance Imaging and Contrast-enhanced Harmonic Ultrasonography in Detection and Location of Prostate Transition-zone Cancer

By Wang R   Chen J-J   Zhou Y-C   Huang M-M   Zhang X-R   Miao H-D  

The Journal of International Medical Research, Vol. 39, Iss. 1, 2011-01 ,pp. : 256-266

Field House Publishing

Access to resources Recommend Favorite

MR Molecular Imaging of Prostate Cancer with a Peptide-Targeted Contrast Agent in a Mouse Orthotopic Prostate Cancer Model

By Tan Mingqian   Burden-Gulley Susan   Li Wen   Wu Xueming   Lindner Daniel   Brady-Kalnay Susann   Gulani Vikas   Lu Zheng-Rong  

Pharmaceutical Research, Vol. 29, Iss. 4, 2012-04 ,pp. : 953-960

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics and Tissue Retention of (Gd-DTPA)-Cystamine Copolymers, a Biodegradable Macromolecular Magnetic Resonance Imaging Contrast Agent

By Wang Xinghe   Feng Yi   Ke Tianyi   Schabel Matthias   Lu Zheng-Rong  

Pharmaceutical Research, Vol. 22, Iss. 4, 2005-04 ,pp. : 596-602

Springer Publishing Company

Access to resources Recommend Favorite

Safety of Gadoterate Meglumine (Gd-DOTA) as a Contrast Agent for Magnetic Resonance Imaging: Results of a Post-Marketing Surveillance Study in Japan

By Ishiguchi Tsuneo  

Drugs in R&D, Vol. 10, Iss. 3, 2010-09 ,pp. : 133-145

Adis International

Access to resources Recommend Favorite

In Vivo Cleavage Rate of a Dextran-bound Magnetic Resonance Imaging Contrast agent: Preparation and Intravascular Pharmacokinetic Characteristics in the Rabbit

By  

Current Drug Delivery, Vol. 10, Iss. 1, 2013-02 ,pp. : 134-143

Bentham Science Publishers

Access to resources Recommend Favorite